Product Information
ROPINIROLE HCL ER 8 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $1.1188 per EA under NDC 43547055703. Its NADAC has been published 196 times since Sep 28, 2022.
Strength
8 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547055703
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ROPINIROLEApproval Type
Generic (ANDA)
FDA Application
ANDA204413On Market Since
3/22/2022
Pharmacological Classes
Price Statistics
The NADAC for ROPINIROLE HCL ER 8 MG TABLET has been published 196 times since Sep 28, 2022, and over the history we have for it it has risen 33.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1188 per EA |
|---|---|
| All-time high | $1.8018 (Dec 11, 2024) |
| All-time low | $0.7082 (Nov 23, 2022) |
| 52-week high | $1.5441 |
| 52-week low | $0.7180 |
| Median price | $1.3335 |
| Average price | $1.2923 |
| Largest weekly change | +104.0% (Dec 21, 2022) |
| Weeks tracked | 196 |
| Tracking since | Sep 28, 2022 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ROPINIROLE HCL ER 8 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROPINIROLE HCL ER 8 MG TABLET, manufactured by Solco Healthcare US LLC, is $1.1188 per EA (NDC 43547055703), effective Jun 24, 2026.
How has the price of ROPINIROLE HCL ER 8 MG TABLET changed over time?
Over the history we have for it, the NADAC for ROPINIROLE HCL ER 8 MG TABLET has risen 33.2%. It has been tracked across 196 weekly CMS publications since Sep 28, 2022.
What are the highest and lowest recorded NADAC prices for ROPINIROLE HCL ER 8 MG TABLET?
Since Sep 28, 2022, the NADAC for ROPINIROLE HCL ER 8 MG TABLET has ranged from a low of $0.7082 (Nov 23, 2022) to a high of $1.8018 (Dec 11, 2024), with a median of $1.3335 per EA.
Are there cheaper alternatives to ROPINIROLE HCL ER 8 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as ROPINIROLE HCL ER 8 MG TABLET, but none are currently priced below it.
Who manufactures ROPINIROLE HCL ER 8 MG TABLET?
ROPINIROLE HCL ER 8 MG TABLET (NDC 43547055703) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification